Long-term outcomes in a Hispanic Population with Rheumatoid Arthritis Receiving Early Therapy with Disease-Modifying Anti-Rheumatic Drugs.

被引：0
|
作者：
Santiago-Casas, Yesenia [1 ]
Gonzalez-Rivera, Tania C. [2 ]
Castro-Santana, Lesliane E. [1 ]
Rios, Grissel [1 ]
Martinez, David [1 ]
Rodriguez, Vanessa E. [1 ]
Mayor, Angel M. [1 ]
Gonzalez-Alcover, Rafael [1 ]
Vila, Luis M. [1 ]
机构：
[1] Univ Puerto Rico, San Juan, PR 00936 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4015 / 4015
页数：1
相关论文
共 50 条
  • [1] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    [J]. CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [2] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [3] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [4] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [5] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Clélia Monchablon
    Henri Gondé
    Sophie Pouplin
    Rémi Varin
    Olivier Vittecoq
    Thierry Lequerré
    [J]. Clinical Rheumatology, 2020, 39 : 207 - 216
  • [6] Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis
    Mullan, RH
    Bresnihan, B
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (05) : S158 - S164
  • [7] Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs
    Pavelka, Karel
    Kavanaugh, Arthur F.
    Rubbert-Roth, Andrea
    Ferraccioli, Gianfranco
    [J]. RHEUMATOLOGY, 2012, 51 : V12 - V21
  • [8] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [9] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [10] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    [J]. SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
12345